Rooted Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Rooted Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,786	Closed	-$1.47M	–	97
2024 Q4	$1.47M	Buy	15,786 +2,199	+16%	+$213K	0.57%	34
2024 Q3	$1.31M	Sell	13,587 -1,264	-9%	-$124K	0.58%	32
2024 Q2	$1.45M	Buy	14,851 +1,513	+11%	+$136K	0.64%	31
2024 Q1	$1.21M	Sell	13,338 -1,293	-9%	-$120K	0.6%	37
2023 Q4	$1.31M	Buy	14,631 +696	+5%	+$51.7K	0.69%	33
2023 Q3	$1.01M	Buy	+13,935	New	+$1.11M	0.62%	33

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Rooted Wealth Advisors's XBI Position: Q1 2025 in Review

Rooted Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 15,786 shares — an estimated $1.47M sold.

Rooted Wealth Advisors first reported a position in XBI in Q3 2023 and held it in 6 quarters. The position peaked at $1.47M in Q4 2024. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Rooted Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Rooted Wealth Advisors sold 15,786 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.47M.
Rooted Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 6 quarters.
Rooted Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.47M in Q4 2024.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Rooted Wealth Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.